PMID- 16412786 OWN - NLM STAT- MEDLINE DCOM- 20060516 LR - 20220330 IS - 0037-1963 (Print) IS - 0037-1963 (Linking) VI - 43 IP - 1 DP - 2006 Jan TI - The clinical spectrum of acute graft-versus-host disease. PG - 24-31 AB - Acute graft-versus-host disease (GVHD), initiated by the reaction of donor T lymphocytes against nonshared recipient antigens, typically leads to a clinical syndrome characterized by cutaneous eruptions and intestinal and hepatic dysfunction. These three organ systems are considered in the clinical grading of acute GVHD. However, other targets may be involved. With conventional transplant conditioning regimens and in vivo prophylaxis, GVHD becomes clinically manifest within 2 to 4 weeks. With reduced-intensity conditioning, the onset of acute GVHD may be delayed until 2 to 3 months after transplantation. Hyperacute GVHD may occur within a week of transplantation after severely human leukocyte antigen (HLA)-mismatched transplants or transplants without GVHD prophylaxis. There is no reliable laboratory test for acute GVHD, and the diagnosis is based on clinical assessment. FAU - Deeg, H Joachim AU - Deeg HJ AD - Fred Hutchinson Cancer Research Center, Seattle WA 98109-1024, USA. jdeeg@fhcrc.org FAU - Antin, Joseph H AU - Antin JH LA - eng GR - CA15704/CA/NCI NIH HHS/United States GR - CA18029/CA/NCI NIH HHS/United States GR - HL36444/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review PL - United States TA - Semin Hematol JT - Seminars in hematology JID - 0404514 SB - IM MH - Acute Disease MH - Graft vs Host Disease/*diagnosis/pathology MH - Humans RF - 83 EDAT- 2006/01/18 09:00 MHDA- 2006/05/17 09:00 CRDT- 2006/01/18 09:00 PHST- 2006/01/18 09:00 [pubmed] PHST- 2006/05/17 09:00 [medline] PHST- 2006/01/18 09:00 [entrez] AID - S0037-1963(05)00168-X [pii] AID - 10.1053/j.seminhematol.2005.09.003 [doi] PST - ppublish SO - Semin Hematol. 2006 Jan;43(1):24-31. doi: 10.1053/j.seminhematol.2005.09.003.